Distribution Characteristics and Prognostic Value of Immune Infiltration in Oligometastatic Breast Cancer

被引:3
作者
Zhou, Danyang [1 ]
Jiang, Kuikui [1 ]
Hong, Ruoxi [1 ]
Lu, Qianyi [1 ]
Xia, Wen [1 ]
Li, Mei [2 ]
Zheng, Chengyou [2 ]
Zheng, Qiufan [1 ]
Xu, Fei [1 ]
Wang, Shusen [1 ]
机构
[1] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Dept Med Oncol,Collaborat Innovat Ctr Canc Med, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Dept Pathol,Collaborat Innovat Ctr Canc Med, Guangzhou, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
基金
中国国家自然科学基金;
关键词
immune infiltration; primary tumor; oligometastatic lesion; intratumoral; peritumoral; prognostic value; oligometastatic breast cancer; COLORECTAL-CANCER; T-CELLS; SURVEILLANCE; LYMPHOCYTES; MECHANISMS; LANDSCAPE; DISEASE;
D O I
10.3389/fonc.2021.747012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundTo assess the distribution characteristics and the prognostic value of immune infiltration in female oligometastatic breast cancer patients. MethodsWe retrospectively analyzed the clinicopathological data of oligometastatic breast cancer (OMBC) patients diagnosed between June 2000 and January 2020. Immune markers were quantified by immunohistochemistry on FFPE tissues in paired normal breast tissues, primary breast cancers and oligometastatic lesions. Survival analyses were performed using the Kaplan-Meier curves and Cox-proportional hazards model. ResultsA total of 95 female OMBC patients visited Sun Yat-sen University Cancer Center between June 2000 and January 2020, and 33 of them had matched normal breast tissues, primary cancers and oligometastatic lesions and were reviewed in immune infiltration analysis. CD8 of primary tumors had a higher expression than that in matched normal tissues. The expressions of CD8 and FOXP3 were higher in the primary sites than that in the oligometastatic lesions. CD3, CD4 and CD8 were significantly lower in the intratumoral regions than that in the peritumoral regions both in primary and oligometastatic lesions. Notably, the high percentage of CD3 in the intratumoral oligometastatic lesions predicted the longer PFS and OS, and higher CD4 in the same lesions also predicted a better OS. There was obviously positive correlation between CD4/CD3 and Ki-67 in primary cancers and negative correlation between CD4/CD3 and ER in oligometastatic sites. ConclusionWe explored immune distribution and evolution in time and space in OMBC to provide new understandings for biological behaviors of this disease and further divided patients in different prognosis.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer
    Liu, Lina
    Wang, Yuhua
    Miao, Lei
    Liu, Qi
    Musetti, Sara
    Li, Jun
    Huang, Leaf
    [J]. MOLECULAR THERAPY, 2018, 26 (01) : 45 - 55
  • [22] Oligometastatic Breast Cancer: Is This a Curable Entity? A Contemporary Review of the Literature
    Makhlin, Igor
    Fox, Kevin
    [J]. CURRENT ONCOLOGY REPORTS, 2020, 22 (02)
  • [23] Matkowski R, 2009, ANTICANCER RES, V29, P2445
  • [24] Activation of ERα Signaling Differentially Modulates IFN-γ Induced HLA-Class II Expression in Breast Cancer Cells
    Mostafa, Ahmed A.
    Codner, Dianne
    Hirasawa, Kensuke
    Komatsu, Yumiko
    Young, Matthew N.
    Steimle, Viktor
    Drover, Sheila
    [J]. PLOS ONE, 2014, 9 (01):
  • [25] Immune suppressive mechanisms in the tumor microenvironment
    Munn, David H.
    Bronte, Vincenzo
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2016, 39 : 1 - 6
  • [26] Limited M1 Disease: A Significant Prognostic Factor for Stage IV Breast Cancer
    Nguyen, David H. A.
    Truong, Pauline T.
    Walter, Caroline V.
    Hayashi, Emily
    Christie, Jennifer L.
    Alexander, Cheryl
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (09) : 3028 - 3034
  • [27] Extending survival with chemotherapy in metastatic breast cancer
    O'Shaughnessy, J
    [J]. ONCOLOGIST, 2005, 10 : 20 - 29
  • [28] International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured?
    Pagani, Olivia
    Senkus, Elzbieta
    Wood, William
    Colleoni, Marco
    Cufer, Tanja
    Kyriakides, Stella
    Costa, Alberto
    Winer, Eric P.
    Cardoso, Fatima
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (07): : 456 - 463
  • [29] The oligometastatic state-separating truth from wishful thinking
    Palma, David A.
    Salama, Joseph K.
    Lo, Simon S.
    Senan, Suresh
    Treasure, Tom
    Govindan, Ramaswamy
    Weichselbaum, Ralph
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2014, 11 (09) : 549 - 557
  • [30] Activated tumor-infiltrating CD4+regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer
    Pedroza-Gonzalez, Alexander
    Verhoef, Cornelis
    Ijzermans, Jan N. M.
    Peppelenbosch, Maikel P.
    Kwekkeboom, Jaap
    Verheij, Joanne
    Janssen, Harry L. A.
    Sprengers, Dave
    [J]. HEPATOLOGY, 2013, 57 (01) : 183 - 194